The Either-Or Trap: Consequences of Enhanced Mechanical Calibration vs Fully Qualifying your Dissolution Equipment
Join this webinar to understand why mechanical calibration alone may not be sufficient to fully qualify dissolution testing equipment - and learn from experts how USP's improved Dissolution Performance Verification Standard (DPVS) reduces variability and increases confidence in results.
Vinay Prasad to exit CBER as FDA group director
By Catherine Eckford (European Pharmaceutical Review)
CSL breaks ground on $1.5bn Illinois plasma therapy facility expansion
By Catherine Eckford (European Pharmaceutical Review)
Biogen/Stoke’s zorevunersen hailed as potential first disease-modifying drug for rare epilepsy
By Catherine Eckford (European Pharmaceutical Review)
Sanofi gains access to first-in-class JAK inhibitor through $1.5bn licensing deal
By Catherine Eckford (European Pharmaceutical Review)
Transformer-multimodal spectral imaging (TMSI): a novel, AI-driven alternative microbiological method…
By Alexandre Banon, Ali Keshavarzi, Arthur Vivé, Emilia Humeau, Ludovic…
Applying AI to enhance drug formulation and development
By Sanjay Konagurthu (Thermo Fisher Scientific)































